Prod 4Alternative Names: Prod-4
Latest Information Update: 01 Dec 2016
At a glance
- Originator Zydus Cadila
- Class Antineoplastics; Thrombolytics
- Mechanism of Action Undefined mechanism
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Research Cancer; Myocardial infarction
Most Recent Events
- 01 Dec 2016 Early research in Cancer in India (Unspecified route) before December 2016
- 01 Dec 2016 Early research in Myocardial infarction in India (Unspecified route) before December 2016